Equity
Total Equity
AbbVie Total Equity decreased by 103.5% to -$6.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 568.7%, from $1.42B to -$6.66B. Over 5 years (FY 2020 to FY 2025), Total Equity shows a downward trend with a -24.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalHigher is better
VolatilityStable
First reportedQ4 2013
Last reportedQ1 2026May 8, 2026
How to read this metric
A growing equity base generally indicates strong retained earnings and effective capital management.
Detailed definition
Total stockholders' equity represents the residual interest in the assets of the entity after deducting all its liabilit...
Peer comparison
Used as a baseline for calculating Return on Equity (ROE) across all industries.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.57B | $13.55B | $15.41B | $16.28B | $14.65B | $15.99B | $17.25B | $13.27B | $12.87B | $12.09B | $10.36B | $8.01B | $6.78B | $6.03B | $3.33B | $1.42B | -$183.00M | -$2.64B | -$3.27B | -$6.66B |
| QoQ Change | — | +7.8% | +13.7% | +5.7% | -10.0% | +9.2% | +7.9% | -23.1% | -3.1% | -6.0% | -14.3% | -22.7% | -15.3% | -11.0% | -44.9% | -57.3% | -112.9% | <-999% | -23.8% | -103.5% |
| YoY Change | — | — | — | — | +16.6% | +18.0% | +12.0% | -18.5% | -12.2% | -24.4% | -40.0% | -39.7% | -47.3% | -50.1% | -67.9% | -82.3% | -102.7% | -143.8% | -198.3% | -568.7% |
Range-$6.66B – $17.25B
CAGR-12.5%
Avg YoY Growth-84.3%
Median YoY Growth-43.6%
Current Streak13 quarters decline
Total Equity at Other Companies
Frequently Asked Questions
- What is AbbVie's total equity?
- AbbVie (ABBV) reported total equity of -$6.66B in Q1 2026.
- How has AbbVie's total equity changed year-over-year?
- AbbVie's total equity decreased by 568.7% year-over-year, from $1.42B to -$6.66B.
- What is the long-term trend for AbbVie's total equity?
- Over 5 years (2020 to 2025), AbbVie's total equity has grown at a -24.2% compound annual growth rate (CAGR), from $13.08B to -$3.27B.
- What does total equity mean?
- The total net value of the company belonging to shareholders.